ArticleCancers2022

Combination of a Novel Fusion Protein CD3εζ28 and Bispecific T Cell Engager Enhances the Persistance and Anti-Cancer Effects of T Cells.

Feng Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.